Bronchiectasis and COVID-19 infection: a two-way street.

Fecha de publicación: 09/12/2022 Fecha Ahead of Print: 09/12/2022

Autores de IIS La Fe

• Grace Jacqueline Oscullo Yépez

  Autor

• José Daniel Gómez Olivas

  Autor

• Thais Carolina Beauperthuy Levy

  Autor

• Amina Bekki

  Autor

• Alberto García Ortega

  Autor

• 

  Miguel Ángel Martínez García

  Autor

Participantes ajenos a IIS La Fe

• Matera, Maria Gabriella
• Cazzola, Mario

Grupos

• Neumología

  

  Leader

  Miguel Ángel Martínez García

Abstract

Bronchiectasis (BE) has been linked to past viral infections such as influenza, measles, or adenovirus. Two years ago, a new pandemic viral infection severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out and it still persists today, and a significant proportion of surviving patients have radiological and clinical sequelae, including BE. Our aim was to thoroughly review the information available in the literature on the bidirectional relationship between SARS-CoV-2 infection and the development of BE, as well as the impact of this infection on patients already suffering from BE. Available information indicates that only a small percentage of patients in the acute phase of coronavirus disease 2019 (COVID-19) pneumonia develop BE, although the latter is recognized as one of the radiological sequelae of COVID-19 pneumonia, especially when it is caused by traction. The severity of the initial pneumonia is the main risk factor for the development of future BE, but during the COVID-19 pandemic, exacerbations in BE patients were reduced by approximately 50%. Finally, the impact of BE on the prognosis of patients with COVID-19 pneumonia is not yet known.

Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.

Keywords

• Bronchiectasis; Coronavirus; COVID-19; SARS-CoV-2